{"id": "1336408151562850307", "creation": 1607459507.0, "user_id": "271405507", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "und #AstraZeneca #Covid19 #vaccine #AZD1222\n\nThe Lancet\nSafety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK\n\nhttps://t.co/6fV9aumU77", "first_save": 1634559108.199414, "hashtags": ["#ASTRAZENECA", "#COVID19", "#VACCINE", "#AZD1222"]}